Breaking News, Financial News

Financial Report: Abbott 4Q

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Abbott   4Q Revenues: $8.0 billion (+10%) 4Q Earnings: $1.5 billion (+28%) FY Revenues: $30.0 billion (+14%) FY Earnings: $4.9 billion (+35%) Comments: Worldwide pharmaceutical sales were up 10% to $4.6 billion in the quarter, and up 14% to $16.7 billion for the year, driven by Humira, Niaspan, and the TriCor/Trilipix franchise. Humira sales in the quarter were $1.4 billion (+41%) and $4.5 billion for the year (+48%). TriCor/Trilipix sales in the quarter were $455 million (+16%) a...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters